Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05428969
What this trial is testing

Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Faron Pharmaceuticals Ltd 181
Testing effectiveness (Phase 2)UnknownNCT01919866
What this trial is testing

Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells

Who this might be right for
Acute LeukemiasAplastic AnemiaChildhood Solid Tumor
University Children's Hospital Tuebingen 120
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Active Not RecruitingNCT02993146
What this trial is testing

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227
What this trial is testing

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 33
Not applicableLooking for participantsNCT06361641
What this trial is testing

Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes

Who this might be right for
Myeloproliferative NeoplasmPolycythemia VeraEssential Thrombocythemia+1 more
University Hospital, Angers 70
Testing effectiveness (Phase 2)Study completedNCT05454241
What this trial is testing

CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies

Who this might be right for
Hematological Malignancies
Institute of Hematology & Blood Diseases Hospital, China 14
Not applicableEnrolling By InvitationNCT04202094
What this trial is testing

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

Who this might be right for
Childhood CancerHematological Disorders
Universitair Ziekenhuis Brussel 50
Not applicableNot Yet RecruitingNCT07018310
What this trial is testing

Micro Assays for HemATology Malignancies Antibody Treatment

Who this might be right for
Hematological Malignancy
Assistance Publique Hopitaux De Marseille 166
Not applicableUnknownNCT02885623
What this trial is testing

Role of CX3CR1-expressing Cells in Hematologic Malignancy

Who this might be right for
CX3CR1 ProteinDiffuse Large B Cell LymphomaMultiple Myeloma
Saint Vincent's Hospital, Korea 50
Early research (Phase 1)Study completedNCT00990717
What this trial is testing

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
University Health Network, Toronto 8
Not applicableStudy completedNCT00333190
What this trial is testing

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyAMLALL+4 more
Dana-Farber Cancer Institute 30
Early research (Phase 1)Study completedNCT05506982
What this trial is testing

Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Emory University 11
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Testing effectiveness (Phase 2)Study completedNCT00353860
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

Who this might be right for
ImmunosuppressionLeukemia
National Heart, Lung, and Blood Institute (NHLBI) 70
Testing effectiveness (Phase 2)Study completedNCT00185640
What this trial is testing

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Who this might be right for
Blood CancerLeukemia
Stanford University 303
Post-approval studies (Phase 4)Study completedNCT04745910
What this trial is testing

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmTumor Lysis Syndrome
M.D. Anderson Cancer Center 10
Not applicableEnded earlyNCT01148160
What this trial is testing

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Who this might be right for
Invasive Fungal Infection
Asan Medical Center 10
Early research (Phase 1)Study completedNCT01399840
What this trial is testing

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia+1 more
Pfizer 33
Next Page